Amai Proteins
its engineered sweet protein sweelin received FDA GRAS clearance in February 2026 and Singapore Food Agency approval in May 2026, with clinical trial results published in the journal Food Chemistry confirming blood-glucose safety.
- Country
- Israel
Coverage
| EU | US | |
|---|---|---|
| food-alt-protein | ✓ | ✓ |
Regulatorsfdaefsa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Sweet proteins (brazzein, thaumatin, monellin) | food-alt-protein | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.